Cancer Drug Repository Program
In Ohio, people with cancer who have several medicine drugs they can no longer use—for example, because their strategic plan or dosage has become—can now…
Cancer
Tabrecta (lapatinib) Approved By The FDA
The U.S. Food and Drug Administration recommended Tabrecta (lapatinib) – lung cancer medication against non-small cell lung cancer (NSCLC) that has expanded to other parts…
HER2-Positive Breast Cancer
The key of abemaciclib, fulvestrant, and trastuzumab revealed a significant rise in progression-free survival (PFS) versus standard-of-care chemotherapy plus trastuzumab while giving a tolerable safety…
Heart Illness And Lab Tests
According to the new study, biomarkers that signal whether a patient’s cancer therapy may be hurting their heart have been known. Through the use of…
Breast Cancer Medication Approved By The FDA
Nowadays, the U.S. Food and Drug Administration has established Tukysa (tucatinib) in combination with chemotherapy (trastuzumab and capecitabine) for the therapy of grownup sufferers with…
Signs & Symptoms of Breast Cancer!
Do you know that breast cancer is the second most common cancer among all? It is counted in one of the stellar causes of death…
Ovarian Cancer: Modern Treatment
In ovarian cancer, an illness that returns within six months of employment following platinum-based treatment is described as platinum-sensitive. A patient’s platinum-sensitivity status can vary…
A New Research From Ludwig Cancer Research
A Ludwig Cancer Research research has devised a different type of chimeric antigen receptor (CAR) T cell—a family of promising immunotherapies for cancer—that might be…
Lurbinectedin In SCLC
A new drug application (NDA) has been registered for expedited approval with the FDA for lurbinectedin in sufferers with small-cell lung cancer (SCLC) who have…
Breast Cancer: The Women Killer in 2020
Cancer disease persists to be a principal reason for death in the United States, has taken nearly 600,000 lives in 2019, according to the CDC…